You are not currently logged in
Home
About us
Product overview
Editorial team
Contact us
Login
Local
GMT
Search
Free archives
Free trial
Quick search
Advanced search
Text
Strict
Search language
Natural language
In the whole story
In keywords only
Classification
Select Value
General news
Industry
Cardiology-Nephrology
Cancer
Rheumatology
Respiratory-Dermatology
Aids and Infectious Diseases
Gastroenterology
Diabetes-Endocrinology
Gynaecology-Reproductive Health
Neurology-Psychiatry
Immunology
Profile
Select profile
Aids
Alzheimer
Asthma
Biotech
Breaking news
Cancer
Cardiology
Diabetes
Distribution
European Commission
Generics
Gynaecology-Reproduction
Hepatitis
Immunology
Industry
Infectio-vaccines
Medical congresses
Multiple Sclerosis
Neurology-Psychiatry
Osteoporosis
Parkinson
Patients' associations
Pharmacovigilance
Press reviews
Regulatory affairs
Respiratory
Rheumatology
Stroke
Women's health
Country
Select Value
Austria
Belarus
Belgium
Bulgaria
China
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
India
Ireland
Italy
Japan
Latvia
Lithuania
Netherlands
Norway
Poland
Portugal
Rest of Asia
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom
United States
Dates
From:
To:
Results: 18335
Transgene signs deal with Novartis but biotech's shares fall on news
10/03/2010 15:53 GMT
Roche and the Curie Institute to tackle aggressive breast cancers
10/03/2010 14:25 GMT
Genticel secures funding for cervical cancer treatment
10/03/2010 13:53 GMT
Oxford BioMedica says in talks to re-partner TroVax
10/03/2010 13:03 GMT
Italy's 2010 drugs spending deficit to rise further to 2.7 billion euros - generics association
10/03/2010 12:33 GMT
EU awards 18 million euros for influenza research
10/03/2010 11:46 GMT
Cellzome strengthens links with GSK with potential 500 million euros deal
10/03/2010 11:09 GMT
English press review - Wednesday
10/03/2010 10:38 GMT
German press review - Wednesday
10/03/2010 10:20 GMT
Abbott to boost early/mid-stage pipeline with $450 million Facet Biotech buy
10/03/2010 09:30 GMT
Novartis launches $5 billion bond issue to fund planned Alcon deal
10/03/2010 09:24 GMT
Actelion says FDA rejects Zavesca filing for rare neurodegenerative disorder
10/03/2010 08:41 GMT
AZN starts trial looking for cardio risk-reduction label for Onglyza
10/03/2010 08:24 GMT
German drug cost-cutting plan not likely to be released before March end
09/03/2010 16:59 GMT
Teva appoints new chairman after former steps down due to illness
09/03/2010 16:31 GMT
1 of 1223